Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 12 citing articles:

COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign
M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, et al.
Cureus (2024)
Open Access | Times Cited: 13
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1
M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, et al.
International Journal of Vaccine Theory Practice and Research (2024) Vol. 3, Iss. 2, pp. 1112-1178
Closed Access | Times Cited: 7
Methodological Considerations Regarding the Quantification of DNA Impurities in the COVID-19 mRNA Vaccine Comirnaty®
Brigitte König, Jürgen O. Kirchner
Methods and Protocols (2024) Vol. 7, Iss. 3, pp. 41-41
Open Access | Times Cited: 6
Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan
Miki Gibo, Seiji Kojima, Akinori Fujisawa, et al.
Cureus (2024)
Open Access | Times Cited: 4
Spike protein-related proteinopathies: a focus on the neurological side of spikeopathies
Andreas Posa
Annals of Anatomy - Anatomischer Anzeiger (2025), pp. 152662-152662
Open Access
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2
M. Nathaniel Mead, Stephanie Seneff, Jessica Rose, et al.
International Journal of Vaccine Theory Practice and Research (2024) Vol. 3, Iss. 2, pp. 1275-1344
Open Access | Times Cited: 2
A Case Report of Acute Lymphoblastic Leukaemia (ALL)/Lymphoblastic Lymphoma (LBL) Following the Second Dose of Comirnaty®: An Analysis of the Potential Pathogenic Mechanism Based on of the Existing Literature
Patrizia Gentilini, Janci C. Lindsay, Nafuko Konishi, et al.
(2024)
Open Access
A Case Report of Acute Lymphoblastic Leukaemia (ALL)/Lymphoblastic Lymphoma (LBL) Following the Second Dose of Comirnaty®: An Analysis of the Potential Pathogenic Mechanism Based on of the Existing Literature
Patrizia Gentilini, Janci C. Lindsay, Nafuko Konishi, et al.
(2024)
Open Access
Weaponised Deception
David A. Hughes
Springer eBooks (2024), pp. 215-273
Closed Access
Conceivably Urgent Actions Could Provide Extreme Benefit
Richard Woesler
Dialogo (2024) Vol. 10, Iss. 2, pp. 340-379
Closed Access
The Post-Acute COVID-19-Vaccination Syndrome in the Light of Pharmacovigilance
Barbara Platschek, Fritz Boege
Vaccines (2024) Vol. 12, Iss. 12, pp. 1378-1378
Open Access
Leveraging Next-Generation Sequencing Application from Identity to Purity Profiling of Nucleic Acid-Based Products
Rucha M. Wadapurkar, Swarda Deo, Renuka Khanzode, et al.
Pharmaceutics (2024) Vol. 17, Iss. 1, pp. 30-30
Open Access
Page 1

Scroll to top